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Abstract The full length cDNA encoding a 100 kDa human 
de-ubiquitinating enzyme, referred to as de-ubiqnitinase was ob- 
tained using one clone selected from a randomly sequenced human 
brain cDNA library and specific primers. The sequence of 18 
peptides generated from the de-ubiquitinase isolated from out- 
dated human erythrocytes matched perfectly with the predicted 
amino acid sequence, which would encode a protein containing 
858 amino acids (calculated M r = 95,743 Da). Homology search 
disclosed that the protein is a member of a large family of ubiq- 
uitin C-terminal hydrolases (UCH2), that was defined on the 
basis of the presence of two specific patterns, 'the Cys- and 
His-domains', which are likely to be involved in the de-ubiquiti- 
nating activity [7]. An additional conserved region, 'the aspartic 
acid domain', was also identified, the functional role of which is 
unknown. 
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1. Introduction 
We have recently reported about a human 100 kDa de-ubi- 
quitinating enzyme which was able to cleave both isopeptidic 
bond Gv6-K4s in dimeric branched ubiquitin and peptidic bond 
G76-M I in 'head-to-tail' Ub2 and Ub9 polymers [1]. Km values 
of the enzyme, which we called 100 kDa de-ubiquitinase, 
showed however, a 10-fold preference for the cleavage of Ub 
specific isoamide bonds over 'classical' peptide bonds. On the 
other hand, the 30 kDa ubiquitin C-terminal hydrolase (a mem- 
ber of UCH family 1) was devoid of such specificity [1], in 
agreement with earlier reports [2,3]. Because several isopepti- 
dases and ubiquitin C-terminal hydrolases have been described 
[4,5,6,7], the cDNA cloning of one partially defined 100 kDa 
de-ubiquitinase offers the opportunity to (i) clarify the struc- 
ture/function relationship, (ii) possibly unravel a member of 
new class of ubiquitin specific proteinases, and (iii) to express 
the protein in amounts sufficient for extensive biochemical 
characterization and possible biotechnological usage. To this 
end, partial NH2-terminal sequence determination of peptides 
derived from the enzyme isolated from human erythrocytes, 
was carried out. The data allowed us to select one clone from 
randomly sequenced cDNA from a human brain library [8]. 
*Corresponding author. Fax: (41) (22) 702 55 02. 
Abbreviations." Ub, ubiquitin; UCH, ubiquitin C-terminal hydrolase; 
PVDF, polyvinylidene difluoride; sp, Swissprot; gb, Genbank; gp, Gen- 
pept; pir, protein identification resource; RACE-PCR, rapid amplifica- 
tion of cDNA ends-PCR. 
The full length cDNA clone was obtained by PCR using se- 
lected primers and the 5' anchored PCR amplification tech- 
nique [9-11]. 
We report here the predicted amino acid sequence of the 100 
kDa human de-ubiquitinase, referred to as UBP I_HUMAN 
(splP45974), which suggests that it is a member of a new, grow- 
ing family of ubiquitin C-terminal hydrolases, referred to as 
UCH2 [12]. 
2. Materials and methods 
2.1. Material 
Outdated human blood samples from the Central Hematology Lab- 
oratory of the Geneva Canton Hospital was the source of the 100 kDa 
de-ubiquitinating enzyme, which was purified to homogeneity accord- 
ing to Falquet et al. [1]. 
2.2. Lys-C and trypsin digestions, CNBr cleavage followed by 
microsequencing of selected peptides from the 100 kDa 
de-ubiquitinase 
Enzymic and chemical cleavages, peptide separation by HPLC or 
SDS-Tris-tricine gels [13], transfer to PVDF membranes and microse- 
quencing with a ABI 473A sequencer were carried out according to 
standard methods in our laboratory [14]. Sequences were used to per- 
form a search with the BLAST program [15,16], using the 'tblastn' 
option which reverse-translate th  query peptide and compare the de- 
generated DNA sequence with all nucleotide databases. 
2.3. cDNA cloning 
A human brain cDNA clone, HIBAA66, was obtained from the 
American Type Culture Collection (ATCC) library (see section 3). The 
clone being incomplete, two peptide sequences, not found in the clone 
HIBAA66 were used to design degenerated primers (ID1F, ID2F), 
which were combined with 3 perfectly matching primers based on the 
cDNA sequence of HIBAA66 (I1R, I2R, I3R) (see Fig. 1). All of these 
primers were used for RT-PCR on human brain mRNA (Clontech) 
with Superscript II reverse transcriptase (BRL) and Dynazyme II DNA 
polymerase (Fynnzyme Oy). The second nested reaction, using primers 
ID2F and I3R, allowed us to amplify a band of 1300 bp, which was 
purified, blunted with T4 DNA polymerase (Biofinex) and ligated into 
SmaI site of vector pBluescript II KS. Out of 48 colonies, 7independent 
clones were obtained and were labeled RSTI, -4, -8, -10, -11, -12, -13. 
As the primer ID2F did not correspond to the blocked N-terminal 
region of the enzyme and that some peptide sequences were still not 
assigned to the determined cDNA sequence, the 5' anchored-PCR 
method using the 5' RACE-PCR kit from BRL was carried out to clone 
the ultimate 5' end. The kit was used with 2 perfectly matching primers 
designed from the RST4 sequence: I6R and I4R (Fig. 1). A band at 
around 300 bp was obtained and cloned into Sail site of pBluescript 
II KS, as Sail site was present on both UAP (5" RACE kit) and I4R 
primers. One clone only was obtained (BBS4). This clone was se- 
quenced on both strands and was found to encompass a putative AUG 
initiation codon. 
The 3 clones (BBS4-RST4-HIBAA66), were fused in two steps; 
HIBAA66 and RST4 clones were fused first using the unique HinclI 
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site (pos 1447), while the unique NarI site (pos 230) was used to add 
the last BBS4 base pairs. DNA sequencing was performed in 
pBluescript vector with primers M13R and M13~,8 using a protocole 
based on exonuclease III digestion [17]. The T7-sequencing kit from 
Pharmacia was used with [cz35S]dATP from Amersham. 
Primer' sequences used (see Fig. 1). 
ID2F, 5'-CA( AIG )TA( CIT)GTIG A( AIG )( AIC)G( AIG/C/T)CA( C/ 
T)TT(C/T)AA-3' 




I6R, 5'-[GGGATCC]TCCTGCTTGCGGGAGG- 3' 
2.4. PROSITE consensus patterns 
Patterns for Cys- and His-domain sequences ofUCH2 family mem- 
bers, are: [LIVMFY]-x(3)-[AGC]-[NA]-x-C-[FY]-[LIVMC]-[NS]-[SC]- 
x-[LIVM]-Q and Y-x-L-x-[SAG]-[LIVMT]-x(2)-H-x-G-x(4,5)-G-H-Y, 
respectively [12]. 
3. Results 
Digestions of human erythrocyte de-ubiquitinase with Lys-C 
enzyme and/or CNBr yielded well resolved peptides by SDS- 
PAGE and Tris-tricine gels. After transfer to PVDF mem- 
branes, bands were sliced out and subjected to automated 
Edman degradation; 18 partial NHz-terminal sequences were 
clearly identified. The BLAST search unraveled the presence 
of an expressed sequence tag (EST) derived from a human brain 
cDNA library [8]; sequences from 9 peptides were found to 
match regions of the translated protein sequence predicted 
from a 1.7 kb cDNA clone, HIBAA66 (Fig. 1). Degenerated 
primers, synthesized on the basis of peptide sequences not 
found in HIBAA66 clone, were used to amplify by PCR a 
human brain poly A + mRNA previously subjected to reverse 
transcription. Several clones of 1.3 kb were isolated and desig- 
nated RST. They were all sequenced on both ends (2 × 300 bp) 
with M 13R and M 1348 primers and did not exhibit sequence 
difference, except for the region of the degenerated primer 
ID2F. Clone RST4 was sequenced on both strands and fused 
to HIBAA66 clone, thus yielding a 3 kb cDNA clone encoding 
803 amino acids. The 5' end of the eDNA was obtained through 
the 5' anchored PCR technique [8-10]; the full length cDNA 
sequence comprises 3158 bp and a putative AUG codon, which 
suggest hat the cDNA clone encodes a protein of 858 amino 
acids (calculated Mr = 95,743 Da) with a pI of 4.90 (Fig. 1). The 
predicted human de-ubiquitinase sequence exhibits several 
characteristic structural features: (1) it contains one 'cysteine 
domain' and one 'histidine domain', which have been postu- 
lated as consensus equences involved in de-ubiquitinating ac- 
tivity (Fig. 2) [7,18]. The Cys-domain is N-terminal from the 
His-domain. A third, but short region of homology located in 
between Cys- and His-domains contains a conserved 
QQDXXE 'Asp-domain' sequence (Fig. 2), the functional role 
of which is unknown. (2) The overall predicted protein se- 
quence of the 100 kDa de-ubiquitinase is poorly homologous 
to the yeast DOA4 (splP32571) or the human tre-2 oncogene 
products (splP35125), the latter esembling the 100 kDa human 
enzyme in their enzymatic activity and sequence similarity in 
the Cys- and His-domains only. The closest yeast homologue 
of the 100 kDa human de-ubiquitinase is UBPC protein 
(splP38237). (3) Homology search in the latest data bank up- 
dates disclosed that the human 100 kDa de-ubiquitinase is a 
member of a new, ye t, large family of ubiquitin C-terminal 
hydrolases, designated UCH2, which was defined by 2 specific 
patterns, the Cys- and His-domains [7,12,18]. This family con- 
tains at least 25 proteins, some of which are still hypothetical 
because they are derived from genomic sequences without iden- 
tification of the gene product. Surprisingly, proteins 
HUM_TRNAGT and RAB_TRNAGT were referred to as 
tRNA transglycosylases (gplU30888 and splP40826); however, 
based on their sequences, they definitely belong to UCH2 fam- 
ily. (4) Because the primary structure also suggests consensus 
sequences for metal binding as drawn in Fig. 1, susceptibility 
NLS HxxEH Cys Asp KEKE 
CxxC HxxH domain domain motif 
?? 
92 199 232 275 326 433 499 
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Fig. 1. Full length cDNA sequence encoding the 100 kDa human de-ubiquitinase. (A) Schematic representation f the predicted amino acid sequence 
with identified homology domains; (B) cloning strategy (see section 2); (C) clones identified from expressed sequence tag (EST) libraries [23], 
(gblT11766, gblT11767, gblH15561, and gblH15620); (D) cDNA (EMBL X91349) and predicted amino acid sequences ( plP45974). Underlined 
residues in D refer to identified peptide sequences; boxed sequence r fers to polyA signal. 
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D - 29 CCGTGTGTGGAGAAGCTC~CGGTGTC 
1 ATGGCGGACGTGAGTGAGGAGC.CC~TCAGTAq~FACCGACGATCCGG~CCTAAGGCT~GACCGGG~CACAAAGACGAGTGC 
M A D V S E E A L L S V L P T I R V P K A G D R V H K D E C 
91 GC~GACACGC~GTCTGAA~ACGTCTGTATGAACAC~' I ' I ' i L~AAACAGTATGTGGAGA~ 
A F S F D T P E S E G G L Y V C M N T F L G F G K O Y V E R 
181 CATTTC~ATAAGACCGGCCAGCGAGTCTAC~CCTCCGGCGGACCCGC~cCGAAAGAGGAGGACCCTC~ACAC4~CACTGGAGAC 
H F N K T G O R V Y L H L R R T R R P K E E D P A T G T G D 
271 CCACCCCC,GAAGAAGCC~CGCGGCTGGCTATPGGTGq~rGAAGC~A~CCTTAGCGAGGAGAAGTTTGAATTAGACGAGGATGT( ]  
P P R K K P T R L A I G V E G G F D L S E E K F E L D E D V 
361 AAGAqqYTI~-A'I" I ' I ' IC~-CAGATTAOCTGGAGAq~CGG~TC-GACi~CTGCCTGA~~~G~ 
K I V I L P D Y L E I A R D G L G G L P D I V R D R V T S A 
451 GTGGAGGCCCTACT~GGCCGACTCAGCCTCCCGCAAGCAGGAGG~TC4~GATC~AAGTACGGCAGGTGTCTAAGCATGCC 
V E A L L S A D S A S R ~ Q E V O A W D G E V R Q V S K H A 
541 T ' fCAGC~GCAGTTGGACAACCC~TCCCTCCC~AAGTC~GTGTGACATGAGAGAGAAC~ 
F S L K Q L D N P A R I P P C G W K C S K C D M R E N L W L 
631 AACCTC, ACTGAT~TCCTCTGTGC~CGCTAC~GATGGCAGTf~CAACCACC~GCACTACCGAGAGACA 
N L T D G S I L C G R R Y F D G S G G N N H A V E H Y R E T 
721 GGCTACCCGTTAGCTGTCAAC~CCATCACCCCTGATGGAGCTGACGTGTACTCATATGATGAGGATGACATGGTCCTGGACCCC 
G Y P L A V K L G T I T P D G A D V Y S Y D E D D M V L D P 
811 AGCCI~GCACCTGTCCCAC~GGCATCGACATC~GATGCAGAAGACAGACAAGACGATGACTGAGT~GGAGATAGACATG 
S L A E H L S H F G I D M L K M Q K T D K T ~ T E L E I D M 
901 AACCAGCGGA~TGAATGGGAC~TCCAGGAGTCAGGTGTGOCACTCAAGCCCCTGq~I ' I~CTGGCTACACA~~C 
N O R I G E W E L I O E S G V P L K P L F G P G Y T G I R N 
991 C ' I~TAACAC4L~ACC~CTCTGTC~GGTC~GCATCCC~CI~GAGGAAGTAT~T~~G 
L G N S C Y L N S V V Q V L F S I P D F Q R I(. Y V D K L E K 
1081 ATCT~`CCAGAATGCCCCGACGGACCCTACCCAGGAqq~IV-AGCACCCAGGTGGCCAAC~TGGCC~CGC~GTAq~1L`C 
I F Q N A P T D P T Q D F S T Q V A K L G H G L L S G E Y S 
1171 AAGCCAGTACCGGAGTCGGGCGATC-~GCGGGTGCCAGAACAGAAGGAAG~GATC~q2TC~CCTCGGATG~C~ 
K P V P E S G D G E R V P E Q K E V Q D G I A P R M F K A L 
1261 ATCGGCAAGGC4ZCACCCTGAAT~CACCAACCGGCAGCAGGATGC CC G AGq' I~CTTCACC~ATCAACATGGTGGAGA~T 
I G K G H P E F S T N R Q Q D A Q E F F L H L I N M V E [~ ~q 
1351 TGCCGGAC~TCCTAATGAAGTGTTCCGC~TGGAGGAAAAGATCAAGTGCCTGGCCACAGAGAAGGTGAAGTACACC 
C R S S E N P N E V F R F L V E E K I K C L A T E K V K Y T 
1441 CAGCGAGTTGACTACATCATGCA(X7FGCCTGTGCCCATGGATC~GCCCTTAACAAAGAGGAC~GTACGAGGAGAAGAAGCGG 
Q R V D Y I M Q L p v P M D A A L N K E E L L E Y E E K K R 
1531 CAAGCCGAAGAGGAGAAGATGGCACTGCCAGAACTGG~CCAGGTGCCCT~GCTCTTGCCT~GGCCTACGGGC`CCCCTGAG 
Q A E E E K M A L P E L V R A O V P F S S C L E A Y G A P E 
1621 CAGGTCGATGACTTC~GCACGGCCC~GGCCAAGTCAGTAGC~GACCACACGATI ' I~q ' I~CCTGACTACC~ 
Q V D D F W S T A L Q A K S V A V K T T R F A S F P D Y L V 
1711 ATCCAGATCAAGAAGTI~CACC~AGACTC~TC~GAAACTGGATGTGTCCATCGAGATGCCAGAC.GAGCTC~C 
I O I K K F T F G L D W V P K K L D V S I E M P E E L D I S 
1801 CAGT~GAGC.GGCACAGGGCTGCAGCCCGGAGAGGAGGAC~GACATrGCCCCACCCCTGGTCACTCCGGATGAGCCCAAAGGTAGC 
Q L R G T G L Q P G E E E L P D I A P P L V T P D E P K G S 
1891 C I~qT I~ATGCK/AACGAAGACGAAGACTCC~CCTCAC~CTCTCCGACATCGCCCA~A~~ 
L G F Y G N E D E D S F C S P H F S S P T S P M L D E S V I 
1981 ATCCAGCTGGTGGAGATGGGATIL~CTATGGACGC~CGCAAAGt~TCTACTACACGGGCAACAGCGGGGC~AGGCCC.CCATGAAc 
I Q L V E M G F P M D A C R K A V Y Y T G N S G A E A A M N 
2071 TGGGTCATGTCACACATGGATGATCCAG~ ITVI C -C~CCOCC~TCC~AGTGGGCCGGG~CAAGCC~C 
W V M S H M D D P D F A N P L I I, P G S S G P G S T S A A A 
2161 GACCCCCCTCCTGAGGAcTGTGTGACCACCA~FG9~CTCCATC~CcC~CCAGGCCTT~GcGCTGCGGGCCACGAACAAT 
D P P P E D C V T T I V S M G F S R D 0 A L K A L R A T N N 
2251 AGq'I~AGAACC, C~ACTGGATC~GTCACATI~ACGACCTGGAT(~GCTC,  CCATC-GACATCTCAGAGGGC~ 
S L E R A V D W I F S H I D D L D A E A A M D I S E G R S A 
2341 C4ZCGACTCCATCTCTGAGTCTGTGCCAGTC-GGACCTAAAGTCCGGGATC~GTATCAGC~Lq T 9 G C ~ A G ~  
A D S I S E $ V P V G P K V R D G P G K Y Q L F A F I S H M 
2431 GGCACC~ACCATGTGTGGTCACTACGq~CACATCAAGAAAGAAGGCAGATC43GTGATCrA~A~G~C 
G T S T M C G H Y V C H I K K E G }{ W V I Y N D Q K V C A S 
2521 GAGAAGCcGCCCAAGGACC~ACAqL~TAC~ACCAGAGAGTGGCCAC42TAAGAC~CcTGCCTCACCCCT~ACCAATGAGGG~GG 
E K P P K D L G Y I Y F Y Q R V A S * 
2611 GGAAGACCACCTC~TGAGGGAGAGGGGCTGAGGGATGGACTTCAGCCCC~TACCC~C F I ' I " I~3~CG~G 
2701 GGAAGAAGC~GGCCGTGGGAGAATGC~GGCAGAC.CAGAGG~GCGATAGACTCTc~GGGATGGAGCAGGACGGGGAcGGGAGGG 
2791 GCC GGCCACC~GTCTGTAAGGAGAC~CCCTC~ CCCCC4ZAATC~GTC~C~TGTCGCCCC~C~CC 
2881 CCTGGTGTGGAGGG A GC~TCTCGTTTGTGCGCGTC~TGTAC~TGCATCCTCTCCCAGTGGAGCGATCACCTGTGC~C 
2971 CCC~CCCTGTGTGGTTGGTCAAGGAGGGATGTGAGGGAAATAGGGACCCCCCGAC~CCTCCTGCCTCAGTCTT ICCCCC 
3061 AC CC'q~ "P ' I~  ~ ~  G.~ATGC C.~a~TAC~C C ~ ~ G  TACAA CG G C? 






























of the 100 kDa de-ubiquitinase towards ion chelators was deter- 
mined. De-ubiquitinating activity was not affected by EDTA, 
EGTA or 1,7-phenanthroline, whereas the chelating isomer, 
1,10-phenanthroline, markedly inhibited cleavage into monom- 
eric ubiquitin (to be published elsewhere). 
4. Discussion 
The predicted primary structure of the 100 kDa de-ubiquiti- 
nase isolated from human erythrocytes has been determined 
from cDNA cloning using human brain mRNA and cDNA 
library. Because the entire cDNA sequence is based on 2 
mRNA's each obtained from a different individual, the exist- 
ence of polymorphism cannot be ruled out. The finding of fit 
of 18 peptide sequences with the predicted sequence (Fig. l) 
supports the notion that the 3 cDNA clones (BBS4, RST, 
HIBAA66) encode the complete polypeptide chain of the de- 
ubiquitinase, but does not represent he final evidence. 
The flanking nucleotide sequence around the initiation 
codon, GUCAUGG, exhibits a G at -3  and +4 (Kozak consen- 
sus sequence), which are required otherwise AUG is bypassed 
[19]. Because of the absence of an in-frame stop codon, up- 
Cys Domain 
spIP45974 UBPI_HUMAN 326 
splP35125 TRE2_HUMAN 215 
splP40818 UBPXHUMAN 777 
gplU20657 HSU20657_I 247 
gplU30888 HUMTRNAGT i05 
spIP40826 RABTRNAGT 105 
splP35123 UBPMOUSE 134 
splP25037 UBPI_YEAST i01 
splO01474 UBP2YEAST 728 
splO01477 UBP3_YEAST 460 
splP32571 UBP4_YEAST 562 
splP39944 UBP5YEAST 446 
sp{P38187 UBPBYEAST 140 
spiP38237 UBPCYEAST 349 
splP39967 UBPE_YEAST 134 
splP43593 UBPF_YEAST 109 
sp]P40453 UBP IYEAST 609 
splP39538 UBP JYEAST 364 
splP36026 UBPK_YEAST 298 
gplX84162 SCCHIVDNAI8  527 
gplZ49212 SC9952X6 205 
gplZ49939 SC9959 5 137 
spIP34547 UBPX_CAEEL 27 
gplZ47811 CEK02C4_4 199 
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splP45974 UBPI HUMAN 801 
spiP35125 TRE2_HUMAN 995 
spIP40818 UBPXHUMAN 1051 
gplU20657 HSU206871 820 
gplU30888 HUMTRNAGT 418 
spIP40826 RABTRNAGT 417 
spIP35123 UBP_MOUSE 696 
spIP25037 UBP IYEAST 681 
sp~O01474 UBP2 YEAST 1185 
spiO01477 UBP3_YEAST 844 
splP32571 UBP4YEAST 854 
spIP39944 UBP5_YEAST 755 
spIP38187 UBPB_YEAST 603 
spIP38237 UBPCYEAST 746 
spIP39967 UBPEYEAST 601 
spIP43593 UBRF_YEAST 430 
splP40453 UBPI_YEAST 998 
splP39538 UBPJ_YEAST 1052 
splP36026 UBPK_YEAST 633 
gplX84162 SCCHIVDNA_I8 829 
gplZ49212 SC99~2X6 449 
gpiZ49939 SC99595 411 
splP34547 UBPXCAEEL  323 
gplZ47811 CEK02C44 722 
pirIA49132 faf_DROS 1970 
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Fig. 2. Alignments of Cys-, Asp- and His-domains within the UCH2 family members• Multiple sequence alignments were carried out using CLUSTAL 
W program [24]. From left to right, data bank accession umber, protein's name, position of the NH2-terminal residue of the domains; black boxes, 
100% identity: gray boxes, >50% identity. 
stream of this AUG, the NH2-terminal Met residue remains 
putative. Since the most proximal peptide sequence found in the 
mature protein is located 47 residues C-terminal from the pre- 
dicted N-terminus of the protein, and because the mature pro- 
tein exhibited an apparently blocked NH2-terminal residue, any 
processing mechanisms which would take place between Met-1 
and Asn-48, leading to a new blocked NH2-terminal residue, 
cannot be formally excluded. Identification of the NH2-termi- 
nal blocked peptide is underway in the laboratory. 
The enzyme displays several distinct consensus patterns 
which may be the signature of a particular function (Fig. 1). The 
so-called Cys- and His-domains (Figs. 1 and 2) may be involved 
in the catalytic activity of the enzyme as mutations of the 
conserved Cys in the Cys-domain of DOA4 [7] to Ser or Ala 
resulted in catalytic inactivity; in addition, the presence of both 
Cys- and His-domains appears a necessary requirement for 
activity [7]. Treatment of the enzyme with 1,10-phenanthroline 
almost completely abolished enzymatic activity. Thus, the pres- 
ence of metal ion(s) can be suspected; in fact, compatible con- 
sensus sequences involving Cys and His residues have been 
pinpointed (see Fig. 1). A nuclear localization signal (NLS) has 
also been predicted in the NH2-terminal part of the 100 kDa 
human de-ubiquitinase (Fig. 1) [20,21]. 
Ultimately, a stretch of 18 amino acids containing more than 
60% Lys and Glu residues, known as the KEKE motif(see Fig. 
IA) was recognized. We designate it as pseudo KEKE motif, 
however, because it contains an internal Tyr residue not re- 
corded in other KEKE positive proteins [22]. The presence of 
this motif was postulated to mediate non-covalent association 
between proteins; if this assumption turned out to be true, the 
putative, transient, binding of the 100 kDa de-ubiquitinase to 
the 26S proteasome [25] is of major interest. 
L. Falquet et al./FEBS Letters 376 (1995) 233~37 237 
Acknowledgements. This work was supported, in part, by Grants 31- 
33658.92 and 3100-043373.95ll from the Swiss National Science Foun- 
dation. 
References 
[1] Falquet, L., Paquet, N., Frutiger, S., Hughes, G.J., Hoang-Van, 
K. and Jaton, J.-C. (1995) FEBS Lett. 359, 73-77. 
[2] Pickart, C.M. and Rose, I.A. (1986) J. Biol. Chem. 261, 10210- 
10217. 
[3] Wilkinson, K.D., Deshpande, S. and Larsen, C.N. (1992) Bio- 
chem. Soc. Trans. 20, 631 637. 
[4] Hadari, T., Warms, J.V.B., Rose, I.A. and Hershko, A. (1992) 
J. Biol. Chem. 267, 719-727. 
[5] Zhang, N., Wilkinson, K.D. and Bownes, M. (1993) Dev. Biol. 
157, 214~223. 
[6] Eytan, E., Armon, T., Heller, H., Beck, S. and Hershko, A. (1993) 
J. Biol. Chem. 268, 4668-4674. 
[7] Papa, F.R. and Hochstrasser, M. (1993) Nature 366, 313-319. 
[8] Adams, M.D., Soares, M.B., Kerlavage, A.R., Fields, C. and 
Venter, J.C. (1993) Nature Genet. 4, 373-380. 
[9] Frohman, M.A., Dush, M.K. and Martin, G.R. (1988) Proc. Natl. 
Acad. Sci. USA 85, 8998-9002. 
[10] Ohara, O., Dorit, R.L. and Gilbert, W. (1989) Proc. Natl. Acad. 
Sci. USA 86, 5673 5677. 
[11] Loh, Y., Elliot, J.F., Cwirla, S., Lanier, L.L. and Davies, M.M. 
(1989) Science 243, 217-220. 
[12] Bairoch, A. and Bucher, P. (1994) Nucleic Ac. Res. 22, 3583- 
3589. 
[13] Sch~igger, H. and yon Jagow, G. (1987) Anal. Biochem. 166, 368- 
379. 
[14] Hughes, G.J., Frutiger, S., Paquet, N. and Jaton, J.-C. (1990) 
Biochem. J. 271,641-647. 
[15] Gish, W. and States, D.J. (1993) Nature Genet. 3, 266-272. 
[16] AltschuL S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, 
D.J. (1990) J. Mol. Biol. 215, 403-410. 
[17] Henikoff, S. (1984) Gene 28, 351-359. 
[18] Baker, R.T., Tobias, J.W. and Varshavsky, A. (1992) J. Biol. 
Chem. 267, 3364~3375. 
[19] Kozak, M. (1991) J. Biol. Chem. 260, 19867 19870. 
[20] Dingwall, C. and Laskey, R.A. (1991) TIBS 16, 478-481. 
[21] Roberts, B. (1989) Biochim. Biophys. Acta 1008, 263-280. 
[22] Realini, C.L., Rogers, S.W. and Rechsteiner, M. (1994) FEBS 
Lett. 348, 109-113. 
[23] Liew, C.C. (1994) Proc. Natl. Acad. Sci. USA 91, 10645 
10649. 
[24] Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) Nucleic 
Ac. Res. 22, 4673-4680. 
[25] Peters, J.-M., Franke, W.W. and Kleinschmidt, J.A. (1994) J. Biol. 
Chem. 269, 7709 7718. 
Note added to the proof 
Since this manuscript was submitted, the cDNA sequence of a clone encoding isopeptidase T from human liver cell line HL60 
appeared (accession o. gb/U35166). The sequence was 98% identical to ours. 
